Javascript must be enabled to continue!
Effects of Therapy on the Nature and Quantity of Fuels Oxidized During Diabetic Ketoacidosis
View through CrossRef
We studied seven patients, in moderate to severe diabetic ketoacidosis (DKA), measuring respiratory exchanges of O2, GO2, and acetone and urinary excretion of nitrogen, ketone bodies, and glucose to calculate the respiratory quotient (RQ), nonprotein respiratory quotient (npRQ), metabolic requirements, and calories derived from fat, carbohydrate, and protein oxidation. Results from indirect calorimetry were related to circulating concentrations of glucose, free fatty acids, ketone bodies, and amino acids over a 14-h study consisting of a 2-h period I of rehydration with saline, a 4-h period II of rehydration and insulin therapy, and an 8-h period III of rehydration, insulin, and glucose administration.
During period I, of about 2 h of saline rehydration, the RQ (0.55–0.80) and npRQ (0.58–0.88) varied among the patients but in general was low. The caloric requirements were 1.24 kcal/min/1.73 m2. Initially,fat contributed 78 ± 11%, glucose 17 ± 10%, and protein 5 ± 2% of the metabolic requirements. The circulating concentrations of fuels remained constant. During period II, after about 4 h of saline and insulin therapy, the RQ (0.62–0.88) and npRQ (0.55–0.91) remained rather stable, rising in only two of seven patients. Nevertheless, in all patients, saline and insulin therapy was associated with precipitous decreases in circulating concentrations of glucose, free fatty acids, acetoacetate, and beta-hydroxybutyrate and gradual decreases in plasma amino acids. During period III, after 8–12 h of insulin therapy, the RQ (0.68–0.92) and npRQ (0.48–1.01) increased, rising in five of six patients. Heightened RQ and npRQ values were observed only after plasma free fatty acid concentrations decreased to 0.44 ± 0.12 mM and plasma acetoacetate plus beta-hydroxybutyrate concentrations decreased to 5.27 ± 1.86 mM, while plasma glucose concentration remained elevated at 13.49 ± 3.67 mM because of intravenous glucose infusion.
Caloric requirements diminished progressively throughout the study, and after about 4 h of saline and insulin therapy a reciprocal relationship between the contributions of fat and glucose to metabolic requirements was evident. At the end of period III the caloric requirements were 0.77 kcal/min/1.73 m2. Fat contributed 44 ± 16%, glucose 42 ± 22%, and protein 14 ± 8% of the metabolic requirements.
We have observed a dissociation between the decrease in plasma glucose, free fatty acids, ketone bodies, and amino acids and the nature of fuels oxidized. This suggests that, during the initial hours of therapy for DKA, the predominant effect of insulin is to promote fuel storage rather than to promote glucose and ketone body oxidation. It was 8–12 h in the course of therapy before the npRQ rose, reflecting heightened glucose oxidation and diminished fat oxidation. Metabolic requirements progressively decreased with therapy.
American Diabetes Association
Title: Effects of Therapy on the Nature and Quantity of Fuels Oxidized During Diabetic Ketoacidosis
Description:
We studied seven patients, in moderate to severe diabetic ketoacidosis (DKA), measuring respiratory exchanges of O2, GO2, and acetone and urinary excretion of nitrogen, ketone bodies, and glucose to calculate the respiratory quotient (RQ), nonprotein respiratory quotient (npRQ), metabolic requirements, and calories derived from fat, carbohydrate, and protein oxidation.
Results from indirect calorimetry were related to circulating concentrations of glucose, free fatty acids, ketone bodies, and amino acids over a 14-h study consisting of a 2-h period I of rehydration with saline, a 4-h period II of rehydration and insulin therapy, and an 8-h period III of rehydration, insulin, and glucose administration.
During period I, of about 2 h of saline rehydration, the RQ (0.
55–0.
80) and npRQ (0.
58–0.
88) varied among the patients but in general was low.
The caloric requirements were 1.
24 kcal/min/1.
73 m2.
Initially,fat contributed 78 ± 11%, glucose 17 ± 10%, and protein 5 ± 2% of the metabolic requirements.
The circulating concentrations of fuels remained constant.
During period II, after about 4 h of saline and insulin therapy, the RQ (0.
62–0.
88) and npRQ (0.
55–0.
91) remained rather stable, rising in only two of seven patients.
Nevertheless, in all patients, saline and insulin therapy was associated with precipitous decreases in circulating concentrations of glucose, free fatty acids, acetoacetate, and beta-hydroxybutyrate and gradual decreases in plasma amino acids.
During period III, after 8–12 h of insulin therapy, the RQ (0.
68–0.
92) and npRQ (0.
48–1.
01) increased, rising in five of six patients.
Heightened RQ and npRQ values were observed only after plasma free fatty acid concentrations decreased to 0.
44 ± 0.
12 mM and plasma acetoacetate plus beta-hydroxybutyrate concentrations decreased to 5.
27 ± 1.
86 mM, while plasma glucose concentration remained elevated at 13.
49 ± 3.
67 mM because of intravenous glucose infusion.
Caloric requirements diminished progressively throughout the study, and after about 4 h of saline and insulin therapy a reciprocal relationship between the contributions of fat and glucose to metabolic requirements was evident.
At the end of period III the caloric requirements were 0.
77 kcal/min/1.
73 m2.
Fat contributed 44 ± 16%, glucose 42 ± 22%, and protein 14 ± 8% of the metabolic requirements.
We have observed a dissociation between the decrease in plasma glucose, free fatty acids, ketone bodies, and amino acids and the nature of fuels oxidized.
This suggests that, during the initial hours of therapy for DKA, the predominant effect of insulin is to promote fuel storage rather than to promote glucose and ketone body oxidation.
It was 8–12 h in the course of therapy before the npRQ rose, reflecting heightened glucose oxidation and diminished fat oxidation.
Metabolic requirements progressively decreased with therapy.
Related Results
Mortality and its predictors in Adult Diabetic ketoacidosis patients in East Africa: A 2025 Systematic review and meta-analysis
Mortality and its predictors in Adult Diabetic ketoacidosis patients in East Africa: A 2025 Systematic review and meta-analysis
Background Diabetes ketoacidosis occurs at an estimated rate between 4.6 and 8 episodes per 100 patient-years in individuals with diabetes. Up to 47% of diabetes-related ketoacidos...
Sodium-Glucose Cotransporter-2 Inhibitors in Odontogenic Infections
Sodium-Glucose Cotransporter-2 Inhibitors in Odontogenic Infections
On top of improving glycemic control, sodium-glucose cotransporter-2 inhibitors have been shown to reduce cardiovascular mortality & heart failure hospitalization. Sodium-gluco...
Sodium-Glucose Cotransporter-2 Inhibitors In Odontogenic Infections
Sodium-Glucose Cotransporter-2 Inhibitors In Odontogenic Infections
Abstract
On top of improving glycemic control, sodium-glucose cotransporter-2 inhibitors have been shown to reduce cardiovascular mortality & heart failure hospitalizat...
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Introduction: Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide. A kidney biopsy in a diabetic patient must be considered when non-diab...
FREQUENCY OF FACTORS LEADING TO DEVELOPING OF DIABETES KETOACIDOSIS IN PATIENTS WITH TYPE 1 DIABATES
FREQUENCY OF FACTORS LEADING TO DEVELOPING OF DIABETES KETOACIDOSIS IN PATIENTS WITH TYPE 1 DIABATES
Background: Diabetic ketoacidosis (DKA) is a serious, acute complication of type 1 diabetes mellitus, characterized by hyperglycemia, metabolic acidosis, and ketonemia. Despite adv...
Effects of Dietary Aged Maize with Oxidized Fish Oil on Growth Performance, Antioxidant Capacity and Intestinal Health in Weaned Piglets
Effects of Dietary Aged Maize with Oxidized Fish Oil on Growth Performance, Antioxidant Capacity and Intestinal Health in Weaned Piglets
This study aimed to determine the effects of dietary aged maize with supplementation of different levels of oxidized fish oil on growth performance, nutrient digestibility, serum a...
Recognizing the Gap: A Case Series of Euglycemic and Hyperglycemic SGLT2 Inhibitor-Associated Diabetic Ketoacidosis
Recognizing the Gap: A Case Series of Euglycemic and Hyperglycemic SGLT2 Inhibitor-Associated Diabetic Ketoacidosis
Introduction: Ketoacidosis is a rare but serious side effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i), possibly overlooked in clinical practice. We aim to further char...
SERUM VISFATIN, INSULIN RESISTANCE AND BETA CELL FUNCTION IN TYPE II DIABETIC PATIENTS AND NON-DIABETIC ADULT OFFSPRING WITH POSITIVE PARENTAL HISTORY OF TYPE II DIABETES MELLITUS
SERUM VISFATIN, INSULIN RESISTANCE AND BETA CELL FUNCTION IN TYPE II DIABETIC PATIENTS AND NON-DIABETIC ADULT OFFSPRING WITH POSITIVE PARENTAL HISTORY OF TYPE II DIABETES MELLITUS
Introduction:
Non-diabetic individuals with type II diabetic parents are more susceptible to develop Diabetes. Visfatin; an adipocytokine and an enzyme is linked with glucose...

